ACADIA Pharmaceuticals Inc Working Capital to Net Assets Ratio

Latest as of June 2026: 66.1%

ACADIA Pharmaceuticals Inc working capital to net assets ratio. ACADIA Pharmaceuticals Inc (ACAD) has a Working Capital to Net Assets ratio of 66.1% as of June 2026. Working capital of $863.11 Million (current assets of $1.22 Billion minus current liabilities of $361.44 Million) is measured against net assets of $1.31 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check ACADIA Pharmaceuticals Inc (ACAD) tangible net worth to evaluate the tangible quality of the company's equity base.

WC/NA Ratio

66.1%
Working Capital / Net Assets

Working Capital

$863.11 Million
USD

Current Assets

$1.22 Billion
USD

Current Liabilities

$361.44 Million
USD

Working Capital to Net Assets Ratio of ACADIA Pharmaceuticals Inc (2002–2025)

Working capital to net assets ratio of ACADIA Pharmaceuticals Inc from 2002 to 2025. This chart shows how ACADIA Pharmaceuticals Inc's Working Capital to Net Assets ratio has evolved across 24 annual periods from 2002 to 2025. As of June 2026, the ratio stands at 66.1%, reflecting working capital of $863.11 Million against net assets of $1.31 Billion USD. See operational self-sufficiency of ACADIA Pharmaceuticals Inc to measure how many days the company can operate on defensive assets alone.

ACADIA Pharmaceuticals Inc Working Capital to Net Assets Ratio by Year (2002–2025)

ACADIA Pharmaceuticals Inc working capital to net assets ratio by year from 2002 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for ACADIA Pharmaceuticals Inc from 2002 to 2025, covering 24 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see ACAD total assets.

Year WC/NA Ratio Working Capital (USD) Net Assets Current Assets Current Liabilities Change (pp)
2025 64.0% $785.00 Million $1.23 Billion $1.06 Billion $277.11 Million ▼ -10.2 pp
2024 74.2% $543.45 Million $732.79 Million $938.32 Million $394.87 Million ▼ -9.7 pp
2023 83.8% $361.87 Million $431.75 Million $616.12 Million $254.25 Million ▼ -11.7 pp
2022 95.5% $382.31 Million $400.41 Million $507.94 Million $125.63 Million ▼ -1.0 pp
2021 96.5% $521.75 Million $540.89 Million $617.82 Million $96.07 Million ▼ -1.1 pp
2020 97.6% $611.65 Million $627.01 Million $717.62 Million $105.97 Million ▼ -0.5 pp
2019 98.0% $685.42 Million $699.13 Million $760.25 Million $74.83 Million ▲ +0.7 pp
2018 97.4% $466.54 Million $479.08 Million $526.11 Million $59.56 Million ▲ +0.6 pp
2017 96.8% $324.45 Million $335.29 Million $373.48 Million $49.03 Million ▼ -0.7 pp
2016 97.5% $505.31 Million $518.41 Million $547.90 Million $42.59 Million ▼ -1.2 pp
2015 98.7% $197.09 Million $199.76 Million $218.99 Million $21.90 Million ▼ -1.1 pp
2014 99.8% $308.78 Million $309.49 Million $324.62 Million $15.83 Million ▲ +0.2 pp
2013 99.6% $181.38 Million $182.13 Million $188.36 Million $6.98 Million ▼ -21.1 pp
2012 120.7% $102.60 Million $84.98 Million $108.55 Million $5.95 Million ▲ +10.4 pp
2011 110.4% $25.78 Million $23.36 Million $31.95 Million $6.17 Million ▲ +3.0 pp
2010 107.4% $31.89 Million $29.69 Million $37.85 Million $5.96 Million ▼ -171.3 pp
2009 278.7% $33.77 Million $12.11 Million $48.47 Million $14.71 Million ▲ +181.9 pp
2008 96.9% $51.33 Million $52.99 Million $62.38 Million $11.05 Million ▼ -1.4 pp
2007 98.3% $111.97 Million $113.93 Million $131.25 Million $19.29 Million ▲ +1.1 pp
2006 97.2% $65.25 Million $67.16 Million $85.78 Million $20.53 Million ▼ -0.4 pp
2005 97.6% $38.42 Million $39.37 Million $60.12 Million $21.70 Million ▲ +2.5 pp
2004 95.1% $29.18 Million $30.68 Million $37.82 Million $8.64 Million ▲ +133.2 pp
2003 -38.1% $20.05 Million $-52.67 Million $28.27 Million $8.23 Million ▼ -20.4 pp
2002 -17.7% $7.10 Million $-40.09 Million $13.25 Million $6.15 Million —
pp = percentage points